Showing results (381-390 of 426) with videos related to

Sort By:
Pageof 43
Annals of Internal Medicine|June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized TrialMichael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
European Journal of Heart Failure|February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trialClara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
American Journal of Nephrology|August 19, 2024
Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized TrialMatthew R Weir, Patrick Rossignol, Bertram Pitt, et al.
JACC. Heart Failure|August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHFBertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
JACC. Heart Failure|October 30, 2025
Diet and Clinical Outcomes in a Heart Failure PopulationPhilip Joseph, Mahshid Dehghan, Justin A Ezekowitz, et al.
European Journal of Heart Failure|October 30, 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trialYogesh N V Reddy, Javed Butler, Kevin J Anstrom, et al.
European Heart Journal|March 4, 2020
The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regionsJustina Motiejūnaitė, Eiichi Akiyama, Alain Cohen-Solal, et al.
JACC. Heart Failure|September 28, 2024
Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND SubanalysisAndrew J S Coats, Stefan D Anker, Lars H Lund, et al.
Circulation. Cardiovascular Imaging|February 12, 2026
Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial IntelligenceAdam Ioannou, Michel G Khouri, Takeshi Kitai, et al.
Journal of the American College of Cardiology|November 22, 2023
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection FractionJaved Butler, Steen Z Abildstrøm, Barry A Borlaug, et al.
Pageof 43